Research of past decades has shown that pregnancy miscarriage (PM) and placental insufficiency (PI) underlie severe obstetric pathologies that result in complications of fetal development. The occurrence of PI developed during previous PMs varied from 47.6 to 77.3%. Pregnancy mis carriage can be considered to be the clinical manifestation of PI, which is a common complication in women with a previous history of PM. Endothelial dysfunction in the mother and in the fetoplacental complex are basic causes of PI. The angiotensin-converting enzyme (ACE) plays a key role in maintenance of proper balance between vaso constriction and vasodilatation of blood vessels, and thus, in blood pressure regulation. DNA samples were geno typed for insertion/deletion (I/D) polymorphism of the ACE gene by polymerase chain reaction (PCR) assay. This study shows that the frequency of allele I of the ACE gene in DNA samples from placentae of the women with PM and PI (group 4) is twice as high than in the placentae of women with a PM history but without PI in the current pregnancy (group 3) (64.6 and 30.4%, respectively, p <0.001). Odds ratio (OR) analyses showed that the D/D genotype in placentae increases by 3-fold the risk of PI in women negative for PM history. 
INTRODUCTION
Numerous studies have shown that pregnancy miscar riage (PM) and placental insufficiency (PI) underlie many kinds of severe obstetric pathology that result in complica tions of pregnancy and of fetal development. The occur rence of PI developed during previous PMs varied from 47.6 to 77.3% [1] . Pregnancy miscarriage can be consid ered to be the clinical manifestation of PI. Secondly, PI is a common complication in women with a former history of PM. Compensated and subcompensated forms of PI mani fest as threatened spontaneous abortion or threatened pre mature birth, while decompensated PI may be complicated by early or late spontaneous abortion, delayed miscarriage and premature birth [2] . These clinical complications are considered to be forms of PM. Thus, PI and PM are close ly interconnected, but they can also be treated as independ ent entities.
The etiology of PM and PI includes: hormonal insuffi ciency, abnormal vascularization of the uterus, endome trium lesions due to previous curettages, genital infantil ism, detrimental inflammatory or vascular reactions and thrombophilic complications provoked by autoimmune processes. Consequently, PI in patients with PM is usually treated as a primary abnormality [3] . Placental insuffi ciency often occurs as a secondary consequence of uterine blood-flow abnormalities resulting from, for example, hypo-or hypertension, heart attack, partial detachment of the placenta or inflammatory reaction to genital infection in the mother [4, 5] . Thus, abnormalities of placental blood circulation, including microcirculation failure that leads to defects of efficient metabolic exchange between maternal and fetal tissues, constitute the basic mechanism of PI etiology.
Recent clinical findings attribute a major role, in PI and in PM, to endothelial dysfunction in the mother, the fetoplacental complex and in umbilical cord arteries [6] . The angiotensin-converting enzyme (ACE) occupies a key position in maintenance of a proper balance between vaso constriction and vasodilatation of blood vessels, and thus in blood pressure regulation. The enzyme converts angio tensin I into angiotensin II. Angiotensin II has vasoconstrictor properties, and consequently participates in regula tion of vascular tone [7] [8] [9] [10] . Changes in the concentration of angiotensin II may be very important in regulation of functions of the fetoplacental complex and of blood circu lation in the placenta. Information on the association of the ACE gene polymorphisms and PM/PI is rather scanty [11, 12] . The regulation of a vascular tone by ACE is main ly attributed to insertion/deletion (I/D) of a 287 bp Alu-repeat polymorphism in intron 16 of the ACE gene which affects expression of the ACE gene [6, 13, 14] . The pres ence of the D allele correlates with increase of ACE con centration in blood plasma. The I allele is functionally less active than the D allele [13, 15] . The present study focuses on the analysis of allele and genotype frequencies of the I/D polymorphism of the ACE gene in placentae from parturient women with a history of PI and PM.
MATERIALS AND METHODS
Samples of placentae were obtained from 137 partu rient women from the Maternity Department at the Insti tute of Obstetrics and Gynecology D.O. Otta of the Rus sian Academy of Medical Science, Saint Petersburg, Rus sia. Approval for this study was granted by the local Human Institutional Investigation Committee. They were classified into four groups as follows: group 1 (controls) was composed of 36 parturient women negative for both PM and PI in the present pregnancy (supported by clinicallaboratory, ultrasonic, Doppler and morphological meth ods), group 2 comprised 54 parturient women negative for PM in their obstetric history but positive for PI in the cur rent pregnancy, group 3 composed 23 parturient women positive for PM (with one or more spontaneous abortions, and/or premature birth in their obstetric history) but nega tive for PI in the present pregnancy, and group 4 com prised 24 parturient women with PM in their obstetric history and positive for PI in the current pregnancy.
DNA extraction from placental tissue was carried out according to the technique by Sambrook et al. [16] with some modifications. The I/D polymorphism of the ACE gene was determined by a polymerase chain reaction (PCR) method. Amplification was carried out in a total volume 25 µL that contained 15 nM of each primer (ACE F: 5'-CTG GAG ACC ACT CCC ATC CTT TCT-3', ACE R: 5'-GAT GTG GCC ATC ACA TTC GTC AGA T-3'), 67 mM Tris-HCl (pH 8.8), 16.6 mM of ammonium sulfate, 6.7 mM MgCl 2 , 6.7 µM EDTA, 10 mM mercaptoethanol, 170 mg BSA, 1.0 mM of each dNTP and one unit of Taq-polymerase ('Bion', Moscow, Russia). The PCR was per formed under the following conditions: denaturation at 94°C for 7 min., followed by 30 cycles of amplification at 94°C for 40 seconds, 60°C for 40 seconds, 72°C for 1 min. and 72°C for 5 min. The DNA fragments were separated in a 7% polyacrylamide gel and subsequently stained with ethidium bromide and visualized under ultraviolet light.
A standard chi-square test was used for comparing the genotype and allele frequencies. The relative risk was estimated by odds ratio (OR) and p values of <0.05 were considered to be significant. All confidence intervals (CIs) were calculated at the 95% level. Statistical analysis of results was performed using 'STATISTICA v5.5a' soft ware.
RESULTS
Obstetric history data and some clinical features of pregnancy in the four groups are shown in Table  1 . The average age of patients in group 4 was 31.67 ± 4.57 years which was slightly higher than in the ACE GENE & PREGNANCY COMPLICATIONS other groups. Patients of groups 2 and 4 had a 1.5-fold higher frequency of abnormalities of menstrual function compared to those in group 1. One-third of the women in group 4 suffered temporary sterility.
Cardiovascular disease was common in the patients of all groups. Half the women in group 4 had hypertension or hypotension and varix in their obstetric data. Urogenital infection was present in about one-half of those in groups 1 and 4 (66.2%) and of those in groups 2 and 3 (76.9%), respectively.
Nephropathy as a complication of the current preg nancy was most frequent in women in group 2 (44.9%) ( Table 1) . Obstetric history of the women in group 4 was more complicated by extragenital pathology and nephrop athy than in the women of group 3.
Characteristics of the newborns in four groups are summarized in Table 2 . Their average birth weight was 2840.31 ± 809.31 in group 2 and 2664.52 ± 772.67g in group 4. This discrepancy was primarily due to fetus hypo trophy at the term of pregnancy as well as to premature birth. The average birth length of newborns in groups 2 and 4 was 47.92 ± 6.25 and 47.01 ± 4.95 cm, respectively (Table 2 ). It should be noted that intrauterine growth restriction of fetus confirmed at birth was diagnosed for 39% in group 2 and for 50% of newborns in group 4.
The frequencies of alleles and genotypes of the ACE gene in the four studied groups are shown in frequency of the I/D genotype of placentae in group 1 was 2-fold more when compared to that in group 2 (58.3 and 29.6%, respectively) ( Table 3 ).
In the anamnesis of women with PM, the frequencies of alleles of the ACE gene were also significantly different in the groups of placental samples. The frequency of the I allele in group 3 (PM+ and PI-) was 2-times less frequent compared to group 4 (PM+ and PI+) (30.4 and 64.6%, respectively, p <0.001) ( Table 3 ). The distribution of the genotypes between groups 3 and 4 was also significantly different (p <0.01; df = 2). The frequency of the I/I geno type in group 3 (8.7%) was decreased 5-times compared to group 4 (45.9%). Thus, the I/I genotype of the ACE gene in placentae increases 7-times the risk of PI development in PM+ women (OR: 7.33, CI: 1.86-28.9).
Further analyses included comparison of all the studied groups. Distribution of ACE gene genotypes (D/D, I/D and I/I) varied significantly in four studied groups (р<0.01; df=6). The frequency of the D/D genotype in group 2 (46.4%) was significantly higher than in group 4 (16.6%) (Table 3) . Also, the frequency of the D/D geno type was 2-times lower in group 1 (PM-and PI-) com pared to group 3(PM+ and PI-) (22.2 and 47.8%, respec tively). It should be stressed that the I/I genotype of the ACE gene dominated in placentae from group 4 (45.9%) compared to all other groups, whereas the I/D genotype prevailed in group 1 (58.3%). Thus, the D/D genotype of the ACE gene in placentae is associated with a 3-fold increased risk of PI development in PM-women, whereas the I/I genotype correlates with a 6-fold risk of develop ment of both pathologies.
DISCUSSION
According to some recent data, PI accompanies practi cally all pregnancy complications [18] . Despite modern techniques of complex treatment and preventive mainte nance of PI, the risk of PI in PM remained high and varied between 47.6 and 77.3% [1] . The delicate relation between mother and placenta/ fetus operates during progression of the pregnancy. Former spontaneous abortions and endome tritis could provoke receptor abnormalities in the endometrium, including hormone receptors, and thus initiate unfa vorable hormonal and metabolic shifts as a prerequisite of PI at the present pregnancy [19] .
Some authors classify PI as a display of "disadaption disease" [3] . The modern concept of physiological adapta tion of the maternal organism and her fetus during preg nancy formulated by Wallenburg [20] . To a great extent, the favorable outcome of pregnancy in the case of PI depends on adequate adaptation of various components of cardiovascular systems of the mother and fetus. Recent investigations have shown that endothelial dysfunction in mother, in fetoplacental complex and in arteries of the umbilical cord is one of the ACE GENE & PREGNANCY COMPLICATIONS (7) 75.5% (40) 24.5% (13) 0.57 91.3% (21) 8.7% (2) 54.2% (13) 45.8% (11) 0.004
Number of cases are in parentheses.
leading factors in pathogenesis of PM and PI [6] . Angiotensin-converting enzyme, as a basic component of the renin-angiotensin system, is responsible for conversion of angiotensin I into angioten sin II and for inactivation of bradykinin, and plays a key role in the origin and progression of endothelial dysfunc tion and vasoconstriction [21] . Changes in vascular metab olites affect the functions of the fetoplacental complex and may induce abnormalities of blood circulation in the placenta [7] [8] [9] [10] . The I/D polymorphism of the ACE gene is functionally significant as it may influence the whole renin-angiotensin system that participates in regulation of vascular tone [13] . The I allele is associated with decreased ACE production compared to the D allele. An association of the D allele of with cardiovascular disease, in particular, with hypertension [22, 23] and with some kinds of preeclampsia [24] , has been reported. Since ACE is responsible for processes of vasoconstriction and vaso dilatation in placental tissue, it is logical to assume an association between its allelic variants and development of PI. The results of the present study demonstrate the associ ation between allelic variants of the ACE gene and PI development, and indicate that the D allele may be a risk factor for PI in women without PM in the anamnesis, whereas the I allele may be a risk factor for development of PI on a PM background. At first sight, these results are rather inconsistent. However, the causes of PI in women without PMand with PM in their obstetric history could be quite different. Placental insufficiency is mostly primary in patients with PM. Placental insufficiency during early pregnancy devel ops on a background of hormone abnormalities, inflamma tory processes and changes in ednometrium receptors. Patients without PM have secondary PI, which occurs on the background of a pregnancy complicated by nephrop athy, premature placental separation and extragenital pathology. Thus, we were dealing with rather different groups of patients.
In a case of 'pure' PI (group 3), it's clear-cut correla tion with the D/D genotype of the ACE gene was assessed. The same allele is known to be associated with risk of myocardial infarction at a young age, ischemic heart dis ease, etc. [10, 23] . It can be suggested that the D/D geno type in placentae results in an increase of placental infarc tions and partial detachment of the placenta, and thus it could contribute to abnormalities of blood circulation in the placenta and to development of PI.
The pathogenesis of PI in conjunction with a PM case history could be quite different. Hormonal insufficiency, abnormalities of vascularization and endometrium recep tion owing to previous curet tages, genital infantilism, and the presence of inflammatory and vascular reactions, thrombophilic complications at autoimmune processes are the most important causes of PI [25] . In PM cases, mor phological and functional changes result in abnormalities of placenta maturation, involutive-dystrophic and inflam ma tory abnormalities of pla cental tissue [1, 2, 4] . Owing to this pathogenic background, PI in patients with PM should be treated as a primary character. Homozygosity for the I allele could decrease ACE concentration in plasma, and thus decrease the rate of bradykinin inactivation in the placenta. Reduction of bradykinin level may increase ves sel permeability, and modulate inflammatory reaction, provoking premature interruption of pregnancy.
The differences in frequencies of the ACE alleles between groups 3 and 4 with PI could mainly be due to the complexity of the PI syndrome including pathological changes in the fetus and placenta joined by similar clinical manifestations, but varied in the cause of complications and in a number of development pathways.
Determining which genetic factors influence develop ment of PI is of great importance for understanding the pathophysiological mechanisms of this disorder. Identifi cation of candidate genes that participate in PM and PI has great practical value for prevention of this frequent obstet ric pathology. Our data show that products of the ACE gene in placenta participate in PI development. The D/D genotype is associated with a 3-fold increased risk of PI development in women without PM. The I/I genotype increases by 2.6-fold the risk of PI development in patients positive for PM in obstetric history. Testing for the I/D polymorphism of the ACE gene in chorionic villus cells in the first trimester of pregnancy could be very important for prediction of PI. However, it is still unknown whether the maternal I/D polymorphism may influence development of PM and PI. Identification of genetic markers of PI is still in its infancy but could provide new insight into molecular mechanisms of pathology in obstetrics, gynecology, and clinical medicine as a whole.
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